Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects

计划入组 48 人 · 首次发布于 2025 年 5 月 28 日

Pharmacokinetics and Safety Profiles After Administration of DA-5218 and Co-administration of DA-5218-R1, DA-5218-R2 and DA-5218-R3 in Healthy Adult Volunteers

计划入组 90 人 · 首次发布于 2022 年 7 月 8 日

Bioequivalence Study Between "DA-5215 Tab" and "DA-5215-R Tab"

计划入组 50 人 · 首次发布于 2022 年 5 月 17 日

SAI-4

SAI-EGFR-ECD

DA-302168S

SRI SATHYA SAI CENTRAL TRUST

India

DA VOLTERRA

France

OM SAI PHARMA PACK

India

Sanyou Bio Launches 14-Day Antibody Discovery Workflow, Compressing Lead Molecule Identification from Months to Two Weeks

Sanyou Bio and Baiyunshan Xihe Forge Strategic Alliance to Accelerate AI-Driven Radiopharmaceutical Development

Bayer Partners with ConcertAI to Accelerate Precision Oncology Drug Development Using AI